1-Allyl-2-methylbenzene

Catalog No.: 
ACRKCX913
CAS No.: 
1587-04-8
Molecular Formula: 
C10H12
Molecular Weight: 
132.21
1-Allyl-2-methylbenzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$68.00In stockInquiry
25g95%$317.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Allyl-2-methylbenzene
IUPAC Name1-allyl-2-methylbenzene
MDL No.MFCD00060911
Molecular FormulaC10H12
Molecular Weight132.21
SMILESCC1=CC=CC=C1CC=C
InChI KeySVIHJJUMPAUQNO-UHFFFAOYSA-N
SynonymBenzene, 1-methyl-2-(2-propenyl)- | Benzene, 1-methyl-2-(2-propen-1-yl)- | Toluene, o-allyl- | 2-Allyl-1-methylbenzene | allyltoluene | CS-0198962 | 2-Allyltoluene | O-ALLYLTOLUENE | MFCD00060911 | 1-methyl-2-prop-2-enylbenzene | AS-62580 | EN300-698337 |
CAS No.1587-04-8

Safety Data

Pictogram
CorrosiveFlammableHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H225-H302-H318
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRKCX913 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRKCX913 route product structure diagram
    ACRKCX9131587-04-8In Stock
Inquiry

2. ACRKCX913 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRKCX913 route product structure diagram
    ACRKCX9131587-04-8In Stock
Inquiry

3. ACRKCX913 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRKCX913 route product structure diagram
    ACRKCX9131587-04-8In Stock
Inquiry

Comments (0)